A randomized comparative study between low-dose magnesium sulphate and standard dose regimen for management of eclampsia
Keywords:
Eclampsia, Pritchard’s regime, Low dose magnesium sulphateAbstract
Background: Eclampsia is a hypertensive disorder related to pregnancy, in which there is occurrence of one or more generalized convulsions and or coma, in the absence of other neurologic conditions. It is a common obstetric emergency. It contributes significantly to maternal and perinatal morbidity and mortality. Dr. J. A. Pritchard in 1955, introduced magnesium sulphate for control of convulsions in eclampsia and is used worldwide. Considering the low body mass index of Indian women, a low dose magnesium sulphate regime has been introduced by some authors. The Objective was to compare the efficacy of low dose magnesium sulphate regimen with standard Pritchard’s regimen for eclampsia.
Methods: A prospective randomized study of fifty eclampsia cases, treated with magnesium sulphate (25 each with low dose regime and Pritchard regime) was carried out from October 2010 to January 2012 at MAMC & LNH, New Delhi, India. Results were analysed using Statistical Package of Social Sciences (SPSS) software 17.0.
Results: In the present study, convulsions were controlled in 96% of eclampsia cases with low dose magnesium sulphate regimen. One case i.e. 4% had single episode of recurrence of convulsion, which was controlled by giving additional drugs and shifted to standard dose regimen. There was no maternal mortality.
Conclusions: The maternal and perinatal morbidity and mortality in the present study were comparable to those of standard Pritchard’s regimen. The study did not find a single case of magnesium related toxicity with low dose magnesium sulphate regimen. Low dose magnesium sulphate regimen was found to be safe and effective in eclampsia.
Metrics
References
Seth S, Nagrath A, Singh DK. Comparison of low dose, single loading dose and standard Pritchard regimen of magnesium sulphate in ante-partum eclampsia. Anatol J Obstet Gynecol. 2010;1(1):1-4.
Bangal V B, Purushottam A. Giri, Satyajit P. Gavhane. A study to compare the efficacy of low dose magnesium sulphate regime with Pritchard regime in eclampsia. IJBAR. 2012;3(1):53-7.
Fernando Arias. Hypertensive disorder in pregnancy; Practical Guide to High Risk pregnancy and delivery. 3rd ed. New Delhi: Elsevier publishers;2008:397-437.
Ministry of Health and Family Welfare, India. Annual Report. New Delhi: 2005: 105-111. Available at: http://mohfw.nic.in/WriteReadData/l892s/6960144509Annual%20Report%20to%20the%20People%20on%20Health.pdf. Accessed December 2011.
Bhargava A, Pant R, Chutani I, Singh S R. In search for accelerated recovery from eclampsia. J Obstet and Gynecol India. 2006;56:402-5.
Montan S. Medical prevention of pre-eclampsia. Acta Obstet Gynaecol Scand Suppl. 1997;76(164):111-5.
Duley L. The Eclampsia Trial collaborative Group. Which Anticonvulsant for women with Eclampsia? Evidence from the Collaborative Eclampsia trial Lancet. 1995;345:1455-63.
Begum R, Begum A, Johanson R, Ali MN, Akhtar S. A low dose (“Dhaka”) Magnesium Sulphate regimen for Eclampsia. Acta Obstet Gynecol Scand. 2001;80(11):998-1002.
Pritchard JA, Cunningham, FG Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia evaluation of 245 cases. Am J Obstet Gynecol. 1984:148(7);951-63.
Sardesai S, Maira S, Patil A. Low dose Magnesium Sulphate therapy for Eclampsia and imminent Eclampsia – regimen tailored for Indian women. J Obstet and Gynecol India. 2003;53(6):546-50.
Shilva, Saha SC, Kalra J , Prasad R. Safety and efficacy of low dose magnesium sulphate in the treatment of Eclampsia. Int J Gynecol Obstet. 2007;97(2):150-1.
Bangal V, Kwatra A, Raghav S and Jadhav S. Low dose magnesium sulphate regime for Eclampsia. Pravara Med Rev. 2009;4(3):13-5
Mahajan NN, Thomas A, Soni RN, Gaikwad NL and Jain S M. ‘Padhar Regime’ – a low dose magnesium sulphate treatment for eclampsia. Gynaecol Obstet Invest. 2009;67(1):20-4.
Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol 1984;150:728–33.
Duley LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009 Jan;21(1):CD004661.
Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia – eclampsia. Am J Obstet Gynecol. 1990;162(5):1141-5.
Ekele BA, Muhammed D, Bello L N, Namadina IM. Magnesium sulfate therapy in Eclampsia : the Sokoto (ultra short) regimen. BMC Res Notes. 2009;2:165.
Shokry M, Elsedfy GO, Bassiouny MM, Anmin M, Abozid H. Effects of antenatal magnesium sulphate therapy on cerebral and systemic hemodynamics in preterm newborns. Acta Obstetrica et Gynaecologica. 2010;8(6)9:801-6.
Duley L. Magpie Trial Follow up Collaborative group. The Magpie Trial: A randomized trial comparing magnesium sulphate with placebo for preeclampsia: Outcome for children at 18 months. Br J Obstet Gynaecol. 2007;114(3):289-99.
Chinayon P. Clinical management and outcome of eclampsia at Rajavithi Hospital. J Med Assoc Thai. 1998;81(8):579-85.
